A Randomized, Placebo-Controlled Trial of Hesperidin for Fatigue,Mood, and Cognitive Function in Multiple Sclerosis
Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study is a randomised, double-blind, placebo-controlled trial investigating the effects of Hesperidin supplementation on cognitive function, fatigue, and stress. Participants will be randomly assigned to receive either 500mg of Hesperidin or a matching placebo daily for 12 weeks. The primary outcome is fatigue, with secondary outcomes including cognitive performance and mood. The trial seeks to determine if this dietary intervention offers symptom-alleviating benefits.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Diagnosis of Multiple Sclerosis, Aged 18 years or older.
Locations
Other Locations
United Kingdom
FHMLS, Nutrition Lab
RECRUITING
Swansea
Contact Information
Primary
Hayley Young, PhD
h.a.young@swansea.ac.uk
+44 (0) 1792 295908
Time Frame
Start Date: 2026-01-07
Estimated Completion Date: 2027-01-18
Participants
Target number of participants: 60
Treatments
Active_comparator: Hesperidin
Participants receiving Hesperidin capsules for 12 weeks.
Placebo_comparator: Placebo Comparator
Participants receiving matching placebo capsules for 12 weeks.
Related Therapeutic Areas
Sponsors
Collaborators: BioActor B.V.
Leads: Swansea University